These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3526503

  • 1. [Use of analogs of LHRH in the treatment of precocious puberty].
    Bourguignon JP.
    Rev Med Liege; 1986 May 15; 41(10):446-50. PubMed ID: 3526503
    [No Abstract] [Full Text] [Related]

  • 2. [Growth and precocious puberty. Results of treatment by LHRH analogs].
    Chaussain JL, Hamdani K, Swaenepoel C.
    Arch Fr Pediatr; 1992 Apr 15; 49 Suppl 1():285-6. PubMed ID: 1449381
    [No Abstract] [Full Text] [Related]

  • 3. Adult height in precocious puberty after long-term treatment with deslorelin.
    Oerter KE, Manasco P, Barnes KM, Jones J, Hill S, Cutler GB.
    J Clin Endocrinol Metab; 1991 Dec 15; 73(6):1235-40. PubMed ID: 1955504
    [Abstract] [Full Text] [Related]

  • 4. Clinical review 60: Effects of gonadotropin-releasing hormone analog therapy on adult stature in precocious puberty.
    Kletter GB, Kelch RP.
    J Clin Endocrinol Metab; 1994 Aug 15; 79(2):331-4. PubMed ID: 8045943
    [No Abstract] [Full Text] [Related]

  • 5. Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty.
    Manasco PK, Pescovitz OH, Hill SC, Jones JM, Barnes KM, Hench KD, Loriaux DL, Cutler GB.
    J Pediatr; 1989 Jul 15; 115(1):105-8. PubMed ID: 2661787
    [No Abstract] [Full Text] [Related]

  • 6. [True precocious puberty in girl. Therapy with LHRH analogs].
    Wasikowa R, Iwanicka Z, Pellar J, Hirowska I, Barg E.
    Kinderarztl Prax; 1990 Jul 15; 58(7):335-40. PubMed ID: 2145459
    [Abstract] [Full Text] [Related]

  • 7. Treatment of true precocious puberty with a potent luteinizing hormone-releasing factor agonist: effect on growth, sexual maturation, pelvic sonography, and the hypothalamic-pituitary-gonadal axis.
    Styne DM, Harris DA, Egli CA, Conte FA, Kaplan SL, Rivier J, Vale W, Grumbach MM.
    J Clin Endocrinol Metab; 1985 Jul 15; 61(1):142-51. PubMed ID: 3923027
    [Abstract] [Full Text] [Related]

  • 8. Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty.
    Kamp GA, Manasco PK, Barnes KM, Jones J, Rose SR, Hill SC, Cutler GB.
    J Clin Endocrinol Metab; 1991 Feb 15; 72(2):301-7. PubMed ID: 1991801
    [Abstract] [Full Text] [Related]

  • 9. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM.
    Pediatrics; 2009 Apr 15; 123(4):e752-62. PubMed ID: 19332438
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty.
    Crowley WF, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1981 Feb 15; 52(2):370-2. PubMed ID: 6780592
    [Abstract] [Full Text] [Related]

  • 11. The Use of Gonadotropin-Releasing Hormone Analogs beyond Precocious Puberty.
    Eugster EA.
    J Pediatr; 2015 Aug 15; 167(2):481-5. PubMed ID: 26073104
    [No Abstract] [Full Text] [Related]

  • 12. Growth hormone and GnRHa combination therapy in the management of precocious puberty.
    Khadilkar VV, Khadilkar VV, Maskati GB.
    Indian Pediatr; 2005 Jan 15; 42(1):57-60. PubMed ID: 15695861
    [Abstract] [Full Text] [Related]

  • 13. Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs.
    Brito VN, Latronico AC, Cukier P, Teles MG, Silveira LF, Arnhold IJ, Mendonca BB.
    J Clin Endocrinol Metab; 2008 Jul 15; 93(7):2662-9. PubMed ID: 18460564
    [Abstract] [Full Text] [Related]

  • 14. Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist.
    Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M.
    J Clin Endocrinol Metab; 1985 Jul 15; 61(1):152-9. PubMed ID: 3889035
    [Abstract] [Full Text] [Related]

  • 15. Growth and precocious puberty.
    Chaussain JL, Couprie C, Lacaille F, Simon D, Job JC.
    Acta Paediatr Scand Suppl; 1988 Jul 15; 347():38-43. PubMed ID: 2978196
    [Abstract] [Full Text] [Related]

  • 16. Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.
    Mansfield MJ, Beardsworth DE, Loughlin JS, Crawford JD, Bode HH, Rivier J, Vale W, Kushner DC, Crigler JF, Crowley WF.
    N Engl J Med; 1983 Nov 24; 309(21):1286-90. PubMed ID: 6415479
    [Abstract] [Full Text] [Related]

  • 17. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 18. Depot leuprolide acetate for treatment of precocious puberty.
    Parker KL, Lee PA.
    J Clin Endocrinol Metab; 1989 Sep 18; 69(3):689-91. PubMed ID: 2503536
    [Abstract] [Full Text] [Related]

  • 19. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty.
    Manasco PK, Pescovitz OH, Feuillan PP, Hench KD, Barnes KM, Jones J, Hill SC, Loriaux DL, Cutler GB.
    J Clin Endocrinol Metab; 1988 Aug 18; 67(2):368-72. PubMed ID: 3292562
    [Abstract] [Full Text] [Related]

  • 20. Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height.
    Traggiai C, Perucchin PP, Zerbini K, Gastaldi R, De Biasio P, Lorini R.
    Eur J Endocrinol; 2005 Sep 18; 153(3):463-4. PubMed ID: 16131610
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.